| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| SEAWELL A BROOKE | Director | C/O NVIDIA CORPORATION, 2788 SAN TOMAS EXPRESSWAY, SANTA CLARA | /s/ Rebecca Peters, Attorney-in-Fact for A. Brooke Seawell | 01 Jul 2025 | 0001197652 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NVDA | Common Stock | Sale | $3,206,697 | -20,463 | -1.2% | $156.71 | 1,658,898 | 30 Jun 2025 | By Administrative Trust | F1, F2, F3 |
| transaction | NVDA | Common Stock | Sale | $4,171,842 | -26,519 | -1.6% | $157.32 | 1,632,379 | 30 Jun 2025 | By Administrative Trust | F1, F3, F4 |
| transaction | NVDA | Common Stock | Sale | $621,354 | -3,930 | -0.24% | $158.11 | 1,628,449 | 30 Jun 2025 | By Administrative Trust | F1, F3, F5 |
| transaction | NVDA | Common Stock | Sale | $942,501 | -6,194 | -0.38% | $152.16 | 1,622,255 | 01 Jul 2025 | By Administrative Trust | F1, F3, F6 |
| transaction | NVDA | Common Stock | Sale | $2,202,865 | -14,391 | -0.89% | $153.07 | 1,607,864 | 01 Jul 2025 | By Administrative Trust | F1, F3, F7 |
| transaction | NVDA | Common Stock | Sale | $552,772 | -3,590 | -0.22% | $153.98 | 1,604,274 | 01 Jul 2025 | By Administrative Trust | F1, F3, F8 |
| transaction | NVDA | Common Stock | Sale | $499,818 | -3,224 | -0.2% | $155.03 | 1,601,050 | 01 Jul 2025 | By Administrative Trust | F1, F3, F9 |
| transaction | NVDA | Common Stock | Sale | $3,484,728 | -22,318 | -1.4% | $156.14 | 1,578,732 | 01 Jul 2025 | By Administrative Trust | F1, F3, F10 |
| transaction | NVDA | Common Stock | Sale | $317,271 | -2,023 | -0.13% | $156.83 | 1,576,709 | 01 Jul 2025 | By Administrative Trust | F1, F3, F11 |
| holding | NVDA | Common Stock | 10,387 | 30 Jun 2025 | Direct | ||||||
| holding | NVDA | Common Stock | 1,000,000 | 30 Jun 2025 | By Trust | F12 | |||||
| holding | NVDA | Common Stock | 2,000,000 | 30 Jun 2025 | By Survivor Trust | F13 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2025 to meet estate tax obligations. |
| F2 | Represents weighted average sales price. The shares were sold at prices ranging from $155.990 to $156.970. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F3 | The shares are held by The Rosemary and A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee. |
| F4 | Represents weighted average sales price. The shares were sold at prices ranging from $156.985 to $157.975. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F5 | Represents weighted average sales price. The shares were sold at prices ranging from $157.980 to $158.340. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F6 | Represents weighted average sales price. The shares were sold at prices ranging from $151.560 to $152.540. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F7 | Represents weighted average sales price. The shares were sold at prices ranging from $152.550 to $153.530. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F8 | Represents weighted average sales price. The shares were sold at prices ranging from $153.560 to $154.540. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F9 | Represents weighted average sales price. The shares were sold at prices ranging from $154.560 to $155.425. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F10 | Represents weighted average sales price. The shares were sold at prices ranging from $155.630 to $156.620. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F11 | Represents weighted average sales price. The shares were sold at prices ranging from $156.670 to $156.950. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F12 | The shares are held by The A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee. |
| F13 | The shares are held by The Alexander Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee. |